These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9529134)

  • 1. Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements.
    Andreasson P; Johansson B; Billström R; Garwicz S; Mitelman F; Höglund M
    Leukemia; 1998 Mar; 12(3):390-400. PubMed ID: 9529134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2.
    Höglund M; Johansson B; Pedersen-Bjergaard J; Marynen P; Mitelman F
    Blood; 1996 Jan; 87(1):324-30. PubMed ID: 8547659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities.
    Andreasson P; Johansson B; Arheden K; Billström R; Mitelman F; Höglund M
    Genes Chromosomes Cancer; 1997 Jun; 19(2):77-83. PubMed ID: 9171997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: a combined PCR and Southern blotting analysis.
    O'Connor HE; Butler TA; Clark R; Swanton S; Harrison CJ; Secker-Walker LM; Foroni L
    Leukemia; 1998 Jul; 12(7):1099-106. PubMed ID: 9665196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12p unbalanced translocations.
    Odero MD; Carlson K; Lahortiga I; Calasanz MJ; Rowley JD
    Cancer Genet Cytogenet; 2003 Apr; 142(2):115-9. PubMed ID: 12699886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies.
    Wlodarska I; Marynen P; La Starza R; Mecucci C; Van den Berghe H
    Cytogenet Cell Genet; 1996; 72(2-3):229-35. PubMed ID: 8978784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
    Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
    Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic characterization of rearrangements involving 12p in leukemia.
    Vieira L; Marques B; Cavaleiro C; Ambrósio AP; Jorge M; Neto A; Costa JM; Júnior EC; Boavida MG
    Cancer Genet Cytogenet; 2005 Mar; 157(2):134-9. PubMed ID: 15721634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of myeloid disorders and a t(8;12) (q12;p13).
    Hernández JM; González MB; García JL; Ferro MT; Gutiérrez NC; Marynen P; San Miguel JF
    Haematologica; 2000 Jan; 85(1):31-4. PubMed ID: 10629588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.
    Sato Y; Suto Y; Pietenpol J; Golub TR; Gilliland DG; Davis EM; Le Beau MM; Roberts JM; Vogelstein B; Rowley JD
    Blood; 1995 Aug; 86(4):1525-33. PubMed ID: 7632960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
    Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
    Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies.
    Johansson B; Arheden K; Höglund M; Othzén A; Békássy AN; Turesson I; Heim S; Mitelman F
    Genes Chromosomes Cancer; 1995 Sep; 14(1):56-62. PubMed ID: 8527385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.
    Haferlach C; Bacher U; Kohlmann A; Schindela S; Alpermann T; Kern W; Schnittger S; Haferlach T
    Haematologica; 2011 Jun; 96(6):829-36. PubMed ID: 21422114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia.
    Cavé H; Cacheux V; Raynaud S; Brunie G; Bakkus M; Cochaux P; Preudhomme C; Laï JL; Vilmer E; Grandchamp B
    Leukemia; 1997 Sep; 11(9):1459-64. PubMed ID: 9305598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
    Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
    Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies.
    La Starza R; Stella M; Testoni N; Di Bona E; Ciolli S; Marynen P; Martelli MF; Mandelli F; Mecucci C
    Br J Haematol; 1999 Nov; 107(2):340-6. PubMed ID: 10583222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies.
    Wlodarska I; La Starza R; Baens M; Dierlamm J; Uyttebroeck A; Selleslag D; Francine A; Mecucci C; Hagemeijer A; Van den Berghe H; Marynen P
    Blood; 1998 Feb; 91(4):1399-406. PubMed ID: 9454771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies.
    Dreyling MH; Bohlander SK; Le Beau MM; Olopade OI
    Blood; 1995 Sep; 86(5):1931-8. PubMed ID: 7544647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones.
    Sato Y; Kobayashi H; Suto Y; Olney HJ; Davis EM; Super HG; Espinosa R; Le Beau MM; Rowley JD
    Leukemia; 2001 Aug; 15(8):1193-202. PubMed ID: 11480561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.